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1. INTRODUCTION 
Water-in-oil-in-water (W/O/W) multiple emulsions are 
examples of versatile colloidal systems in which 
dispersions of small water droplets within larger oil 
droplets are themselves dispersed in a continuous 
(external) aqueous phase.
[1-9]
 The inner aqueous core 
(where the hydrophilic macromolecular entity is 
dissolved and/or solubilized) is therefore supported by a 
lipid matrix surrounded itself by an aqueous surfactant 
(outer, continuous) phase. Lipid nanoballoons consist of 
a lipid matrix composed of physiologically compatible 
lipids
[1, 2, 10, 11]
, and can be stabilized by emulsifiers such 
as phospholipids and polyoxyethylene ethers.
[1-3, 12]
 
 
Due to the compartimentalized internal structure of the 
lipid nanoballoons integrating a W/O/W multiple 
emulsion, these versatile colloidal systems present clear 
advantages for encapsulation of hydrophilic 
macromolecular entities, with a concomitant better 
control over releasing of such (therapeutic) molecules.
[1, 
13-17]
 W/O/W multiple emulsion systems are, however, 
thermodynamically more unstable and complex than 
conventional (and simpler) O/W emulsions, mainly due 
to (i) the higher fluidity of the former (promoted by the 
lower viscosity of the external aqueous phase), and (ii) 
the limited weight percentage of lipid used to produce 
multiple emulsion systems.
[3] 
 
When producing a W/O/W multiple emulsion system, 
the lipid concentration needed to produce the lipid 
nanoballoons must be kept at low levels, since high lipid 
concentrations further enhance the thermodynamic 
instability of these systems and may even promote their 
rupture (following release of the inner aqueous core 
under shear rate, with concomitant expulsion of the 
water-soluble protein entities through the oily layer 
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between both water phases).
[3, 18, 19]
 To overcome these 
limitations, two emulsifying agents are required, viz. one 
with a low value of hydrophilic-lipophilic balance 
(HLB), added to the lipid phase to stabilize the primary 
W/O emulsion, and another with a high value of HLB, 
added to the external aqueous phase to stabilize the 
secondary (W/O)/W emulsion.
[1-3, 7, 13, 18, 20]
 The two 
surfactants are needed to stabilize the two existing 
interfaces in w/o/w multiple emulsions.
[1, 2, 13]
 
 
Formulating a W/O/W multiple emulsion involves, 
therefore, optimizing processing parameters such as the 
composition of the oily phase, both the types and HLB-
values of the emulsifiers, the effect of the ratio of 
hydrophilic/lipophilic emulsifiers, the effect of the 
oil/water phase ratios, and the effect of processing 
variables such as homogenization speed, to achieve 
formation of stable multiple emulsion systems. Hence, a 
statistical factorial design is mandatory to develop an 
optimal W/O/W multiple emulsion formulation 
integrating biomimetic aqueous-core lipid nanoballoons 
able to house (hydrophilic) protein entities with 
concomitant structural and functional stabilization of 
their three-dimensional structure. In the research effort 
entertained herein, construction of a full statistical 2
3
x3 
factorial design study aimed at establishing the influence 
of multiple factors on multiple emulsion properties 
culminating in the development of a stable W/O/W 
multiple emulsion system integrating small-sized lipid 
nanoballoons with aqueous cores, using Softisan100™ as 
solid lipid, soybean lecithin and poloxamer 188 as low- 
and high-HLB emulsifiers, respectively, and different 
high-shear homogenization speeds. 
 
The aqueous core of lipid nanoballoons integrating a 
W/O/W multiple emulsion system, aimed at mimicking 
the multifunctional design of biological membranes. The 
combined effects of protein entity, and lipophilic 
(soybean lecithin) and hydrophilic (poloxamer 188) 
emulsifier concentrations in the mean particle 
(hydrodynamic) size (HS), zeta potential (ZP) and 
polydispersity index (PI) of the resulting multiple 
emulsion systems, were thus thoroughly studied via a 
2
3
x3 factorial design with triplicate testing for the central 
point, thus allowing not only extraction of a maximum 
amount of information from a limited number of 
experiments, but also to establish the influence of 
multiple factors upon the W/O/W multiple emulsion 
properties. Since HS and PI are the limiting factors for 
using the nasal route of administration, the main aim of 
this experimental full factorial design was to optimize a 
w/o/w multiple emulsion formulation with appropriate 
physicochemical parameters for the encapsulation of 
(hydrophilic) protein entities, envisaging its potential 
utilization in formulating an isotonic suspension for 
aerossolization. The resulting (optimized) W/O/W 
multiple emulsion was subsequently fully characterized 
physicochemically, and the results produced are the 
subject of a forthcoming (part II) manuscript.  
2. MATERIALS AND METHODS 
2.1. MATERIALS 
2.1.1. Chemicals. Lipids: Softisan 100™ (hydrogenated 
coco-glycerides consisting exclusively of saturated 
vegetable fatty acids with chain lengths of C10 – C18) was 
a kind gift from Sasol (Sasol Olefins & Surfactants 
GmbH, Hamburg, Germany). Glycerol (anhydrous) was 
purchased from Labsynth (Diadema/SP, Brazil).  
 
Surfactants: Tween 80 (polyoxyethylene sorbitan 
monooleate) was purchased from Labsynth 
(Diadema/SP, Brazil). Kolliphor P188™ (formerly 
Lutrol F68™, or poloxamer 188) was kindly supplied by 
BASF ChemTrade GmbH (Ludwigshafen, Germany). 
Soybean phosphatidylcholine (lecithin) was purchased 
from Alamar Tecno-Científica Ltda (Diadema/SP, 
Brazil).  
 
Other chemicals: BSA was purchased from Sigma (St. 
Louis MO, USA), and was used without further 
purification. Commercial HCl (37%, w/w) was 
purchased from ECIBRA – Reagentes Analíticos 
(Curitiba/PR, Brazil). Tap water was purified in a Milli-
Q Elga Purelab system (Molsheim, France) to a final 
conductivity of ca. 18.2 M.cm-1. The solvents used 
were all of analytical grade or better, and were used 
without further purification. 
 
2.1.2. Analytical equipment. The Zeta Potential, 
Hydrodynamic Size and Polidispersity Index of the 
multiple emulsion particles were determined in a 
ZetaPALS system (model NanoBrook 90PlusPALS) 
from Brookhaven Instruments (Holtsville NY, U.S.A.). 
 
2.2. Experimental procedures 
2.2.1. Experimental factorial design. A 2
3
x3 full 
factorial design approach (encompassing three variables 
each one set at two levels and one variable set at three 
levels) with triplicate testing for the central (0) level, 
thus requiring a total of eleven formulations producing 
thirty three experiments, was applied to fully maximize 
the experimental efficiency with a minimum of 
experiments. The three different variables (protein 
concentration, lecithin concentration and poloxamer 188 
concentration) at two levels each, low (-1) and high (+1), 
and the one variable (stirring speed) at three levels, low 
(7500 rpm), medium (10000 rpm) and high (12500 rpm), 
and their influence upon the physicochemical properties 
of the multiple emulsions produced (MEi) were duly 
studied. The factorial design undertaken demanded a 
total of 24 experiments, added with the medium levels 
for the first three variables which, combined with the 
three stirring speed levels, produced three additional 
experiments replicated three times each. The total 
number of experiments was, therefore, 33. The 
independent variables were protein concentration, 
lecithin (lipophilic surfactant) concentration, poloxamer 
188 (hydrophilic surfactant) concentration and stirring 
speed, whereas the established dependent variables under 
scrutiny were the mean particle (hydrodynamic) size 
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(HS), Zeta Potential (ZP) and polydispersity index (PI). 
For each independent variable, the low, medium and 
high values of the lower, central and upper levels were 
assigned a (-1), (0) and (+1) sign, respectively (see Table 
1). The data gathered was duly analyzed using Minitab® 
statistical software (release 14.12.0 from Minitab Inc., 
State College PA, U.S.A.). 
 
Table 1. Full 2
3
x3 factorial design, providing the lower (-1), central (0) and upper (+1) level values for each 
variable. 
Independent variables 
Levels 
Low level Central level Upper level 
(-1) (0) (+1) 
Protein (%, w/w) 0.005 0.010 0.015 
Soybean lecithin (%, w/w) 0.250 0.500 0.750 
Poloxamer 188 (%, w/w) 0.500 1.000 1.500 
RPM 7500 10000 12500 
 
2.2.2. Production of W/O/W multiple emulsions 
housing protein entities. The process for producing the 
water-in-oil-in-water (W/O/W) multiple emulsions 
housing protein entities was carried out in two high-
speed homogenization cycles, using an UltraTurrax 
(model T25D from IKA Werke GmbH & Co. KG, 
Staufen, Germany) homogenizer at a constant 
temperature (ca 39 °C). Two emulsions were prepared 
sequentially, a primary (simple) emulsion (Win/O), 
followed by emulsification of this emulsion in another 
(external) aqueous phase (Wext), thus forming a (second) 
multiple emulsion of the type water-in-oil-in-water 
(Win/O/Wext). 
 
2.2.2.1. Preparation of the primary emulsion (Win/O). 
In a thermostatted bath set at 39 °C, the lipid (Softisan 
100™) and the lipophilic emulsifier (soybean lecithin) 
were melted down in a beaker together with glycerol 
(constituting the Oily phase) and, in a separate beaker, 
the internal aqueous phase containing the protein entity 
was heated up to the same temperature. Following 
melting of the oily phase, it was added with 1 mL of the 
internal aqueous phase, followed by high-performance 
homogenization (10 min at either 7500, 10000 or 12500 
rpm). The detailed composition of the Win/O primary 
emulsion is described next. The inner aqueous phase was 
constituted by HCl 10 mM, Tween 80 and pure protein 
entity; the intermediate oily phase encompassed glycerol, 
Softisan 100™ and soybean phosphatidylcholine; finally, 
the outer aqueous phase encompassed poloxamer 188 
and ultrapure water. Control multiple emulsions were 
also produced, without protein entity. The 
aforementioned solid lipid was tested as possible 
constituent of the oily phase, since it is considered a lipid 
for modified release formulations. All formulations 
prepared exhibited a milky and uniform appearance. The 
oily phase (O) was prepared by melting together 500 mg 
Softisan 100™ and 250 mg lecithin on a thermostatted 
bath set at ca. 39 °C and maintained at this temperature. 
In a separate beaker, 5 mL glycerol was heated up to ca. 
39 °C in the same thermostatted bath. For the internal 
aqueous phase (Win), 5 mL HCl 10 mM and 50 mg 
Tween 80™ were heated together up to ca. 39 °C in the 
same thermostatted bath, and added with 25 mg pure 
protein. When Softisan 100™ and lecithin were melted 
down, both glycerol and 1 mL of Win were added and 
thoroughly mixed for 10 min at either 7500, 10000 or 
12500 rpm, in the thermostatted bath, thus forming an 
Win/O emulsion. 
 
2.2.2.2. Preparation of the (Win/O)/Wext multiple 
emulsion. At the end of the first homogenization cycle, 
the external aqueous phase (Wext) was then added and a 
new homogenization cycle performed (10 min at either 
7500, 10000 or 12500 rpm). Therefore, final 
Win/O/Wext dispersions of protein entity were obtained 
via sequential (optimized) homogenization of a Win/O 
dispersion involving two cycles at either 7500, 10000 or 
12500 rpm for 10 min. The external aqueous phase 
(Wext) was prepared by dissolving 500 mg poloxamer 
188 in 41.4 mL ultrapure water. 20 mL Wext was then 
heated up in a thermostatted bath set at ca. 39 °C, added 
to the Win/O emulsion produced earlier, and thoroughly 
mixed for 10 min at either 7500, 10000 or 12500 rpm. 
The remainder of the poloxamer 188 solution 
(maintained at room temperature) was then added to the 
emulsion thus produced and gently homogenized using a 
magnetic stirrer at 100 rpm, until room temperature. 
 
2.2.3. Determination of Hydrodynamic Size and Zeta 
potential. The hydrodynamic size (HS) of the aqueous-
core lipid nanoballoons, the polydispersion index (PI) 
and their Zeta potential (ZP) were obtained in triplicate. 
To analyze the several multiple emulsions produced by 
dynamic laser light scattering (DLS), dilutions of 
samples of the multiple emulsions were prepared 
following indications of the manufacturer of the 
analytical equipment (who advocates dilutions in the 
range of 0.0001% (v/v) - 1.0% (v/v), using an 
appropriate diluent) (50 µL of multiple emulsion in 20 
mL ultrapure water, thus producing a 0.25% (v/v) 
dilution of the sample, falling well within the dilution 
range advocated by Brookhaven), duly homogenized 
using a disposable Pasteur pipette, and analyzed in 
triplicate in a ZetaPALS (model NanoBrook 
90PlusPALS, Brookhaven Instruments, Holtsville NY, 
E.U.A), thus producing values for the particle mean 
hydrodynamic size (HS) and polydispersity index (PI), 
while the Zeta potential (ZP) values were gathered from 
microelectrophoretic analyses. 
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3. RESULTS AND DISCUSSION 
3.1. Optimization of the multiple emulsion. For 
producing an optimal W/O/W multiple emulsion 
formulation, possessing small-sized lipid nanoballoons 
with aqueous-core, evenly distributed in the emulsion 
(i.e., with a low polydispersity index), and with a 
sufficiently low Zeta potential to ensure that no 
coalescence occurs, the statistical factorial design 
allowed to produce an emulsion where a larger protein 
(encapsulated) concentration together with a larger 
lipophilic surfactant concentration lead to a smaller 
polydispersion and quite low (negative) Zeta potential 
values. Centrifugation of the optimized W/O/W multiple 
emulsion did not lead to any protein liberation induced 
by bursting nanoballoons (as revealed by UV-VIS 
spectrophotometry), thus evidencing the firm 
encapsulation and concomitant structural and functional 
stabilization of said protein entities, which is in clear 
agreement with previous findings.
[1]
 Although 
mechanical stirring energy is important for producing the 
dispersion, is it not sufficient though; it only overcomes 
the surface tension barrier during the duration of 
homogenization. Therefore, the easiest way to stabilize 
the system is to reduce surface tension, so as to decrease 
the free energy derived from the expansion of the overall 
surface area.
[21]
 Thus, in addition to testing several high-
speed stirrings, increased surfactant levels were tested in 
producing the W/O/W multiple emulsions, since 
tensioactive agents do play an important role in 
stabilizing emulsions. The emulsifiers should provide an 
optimum HLB value to stabilize the interfaces. The 
correct choice of both emulsifiers (lipophilic and 
hydrophilic) will directly affect formation of the oily 
droplets. For this purpose, soybean lecithin was the 
selected lipophilic emulsifier used with a HLB value of 
4, and poloxamer 188 (Kolliphor P188™) was selected 
as hydrophilic emulsifier with a HLB value of 29.
[22]
 
However, most surfactants cannot reduce the interfacial 
tension to levels enough to counteract all the surface free 
energy caused by the tremendous increase in surface area 
during homogenization, and thus emulsions (and, 
particularly, multiple emulsions) are usually considered 
thermodynamically unstable systems.
[1,18,23]
 The main 
particularities of nanosized emulsions (with sub-
micrometric droplet sizes), making them prime 
candidates for biopharmaceutical applications, is their 
greater stability of droplet suspension, a kinetic stability 
that lasts for months (in clear agreement with the results 
produced in the present research effort), stability against 
dilution or even against temperature changes, totally 
unlike the (thermodynamically unstable) microemulsions 
(24). Emulsions are generally thermodynamically 
unstable systems, due to the positive free energy of 
emulsion formation (ΔGf > 0). In the mathematical 
formulation of the second law of thermodynamics, ΔGf 
=γ ×ΔA - T×ΔSf the large positive interfacial energy 
term (λ ΔA) outweighs the entropy of droplet formation 
(ΔSf), also positive. In the equation just mentioned, λ 
represents the surface tension, ΔA represents the surface 
area gained with emulsification, and T represents the 
temperature. The physical destabilization of emulsions is 
thus related to the spontaneous trend towards a minimal 
interfacial area between the two immiscible phases, 
which can be counteracted by producing suitable values 
of Zeta potential (either very negative or very positive). 
And this was indeed achieved in the present research 
effort, as will be seen in the following sections. 
 
3.2. Hydrodynamic size, polydispersity index and 
Zeta potential. The results obtained from the analysis by 
DLS of the several W/O/W multiple emulsions 
formulated according to the factorial design depicted in 
Table 1, are displayed in Table 2. 
Table 2. Response values (HS, PI and ZP, average (n=3) ± ) of the three factors depicted in Table 1 for the 
eleven formulations produced at three different stirring speeds. 
Multiple 
emulsion 
Protein 
(%, w/w) 
Lecithin 
(%, w/w) 
P188 
(%, w/w) 
HS ±  (nm) PI ±  ZP ±  (mV) 
7500 
rpm 
10000 
rpm 
12500 
rpm 
7500 
rpm 
10000 
rpm 
12500 
rpm 
7500 
rpm 
10000 
rpm 
12500 
rpm 
ME01 0.015 0.25 0.50 
237.58 
± 2.33 
210.47 
± 1.37 
140.72 
± 2.83 
0.236 ± 
0.010 
0.257 ± 
0.014 
0.244 ± 
0.021 
-32.87 
± 0.86 
-30.67 
± 1.72 
-28.23 ± 
4.18 
ME02 0.015 0.25 1.50 
234.49 
± 1.20 
178.18 
± 6.56 
167.39 
± 1.95 
0.228 ± 
0.022 
0.246 ± 
0.029 
0.256 ± 
0.004 
-32.59 
± 0.99 
-26.34 
± 1.05 
-28.25 ± 
0.62 
ME03 0.015 0.75 0.50 
225.77 
± 3.59 
195.87 
± 2.36 
186.20 
± 2.62 
0.259 ± 
0.011 
0.211 ± 
0.012 
0.206 ± 
0.014 
-35.54 
± 1.09 
-25.68 
± 2.45 
-36.45 ± 
0.93 
ME04 0.015 0.75 1.50 
244.59 
± 5.23 
253.49 
± 3.28 
219.53 
± 3.35 
0.248 ± 
0.009 
0.241 ± 
0.015 
0.215 ± 
0.022 
-38.36 
± 0.62 
-26.41 
± 0.64 
-32.87 ± 
0.51 
ME05 0.005 0.75 1.50 
279.85 
± 2.66 
237.07 
± 22.16 
197.92 
± 4.28 
0.280 ± 
0.007 
0.289 ± 
0.015 
0.236 ± 
0.006 
-34.20 
±0.05 
-28.81 
±2.68 
-32.47 ± 
1.27 
ME06 0.005 0.75 0.50 
220.31 
± 2.88 
201.13 
± 5.11 
212.90 
± 1.39 
0.251 ± 
0.019 
0.241 ± 
0.020 
0.221 ± 
0.013 
-34.08 
± 0.53 
-32.40 
± 0.74 
-34.45 ± 
2.14 
ME07 0.005 0.25 1.50 
244.31 
± 1.55 
201.69 
± 0.80 
178.71 
± 2.59 
0.216 ± 
0.026 
0.239 ± 
0.009 
0.262 ± 
0.004 
-34.39 
± 1.05 
-35.07 
± 0.84 
-24.17 ± 
9.61 
ME08 0.005 0.25 0.50 
193.92 
± 1.67 
163.53 
± 1.54 
149.59 
± 2.32 
0.218 ± 
0.018 
0.218 ± 
0.014 
0.231 ± 
0.022 
-36.74 
± 1.01 
-28.89 
± 3.60 
-32.13 ± 
1.12 
ME09 0.010 0.50 1.00 
221.41 
± 2.50 
189.11 
± 4.08 
184.61 
± 1.46 
0.220 ± 
0.005 
0.248 ± 
0.029 
0.232 ± 
0.012 
-31.51 
± 0.71 
-31.39 
± 0.90 
-35.34 ± 
0.37 
ME10 0.010 0.50 1.00 
219.30 
± 1.55 
221.60 
± 0.90 
183.29 
± 6.96 
0.257 ± 
0.013 
0.244 ± 
0.020 
0.242 ± 
0.010 
-36.14 
± 1.56 
-32.79 
± 0.68 
-33.68 ± 
4.25 
ME11 0.010 0.50 1.00 
233.54 
± 4.80 
179.26 
± 1.99 
172.11 
± 2.28 
0.245 ± 
0.012 
0.245 ± 
0.009 
0.211 ± 
0.008 
-36.49 
± 0.66 
-29.61 
± 1.36 
-33.72 ± 
1.80 
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The optimum results evolved from the statistical analysis 
performed are highlighted in Table 2. The net charge at 
the surface of particles in suspension affects the ionic 
distribution in their immediate surroundings, producing 
an electrical double layer around each particle. When a 
particle moves, the ions within its boundary move with 
it, and vice-versa. Zeta potential is the potential that 
exists at this boundary, with its intensity being an 
indication of the potential stability in the colloidal 
system
[25]
, and depends on the concentration of ions in 
the solvent.  
 
Thus, the main reason why to measure the Zeta potential 
lies in predicting colloidal stability, which in turn 
depends on the interactions between particles. The Zeta 
potential is a measure of the repulsive forces between 
particles, and since the majority of colloidal aqueous 
systems is stabilized via electrostatic repulsion, the larger 
the repulsive forces between particles the smaller the 
probability for them to become closer and form 
aggregates, thus leading to a more stable colloidal 
system. As can be seen in Table 2, the statistical factorial 
design performed let to production of an optimum 
multiple emulsion possessing quite homogeneous 
particles with an average hydrodynamic size of (186.2 ± 
2.6) nm and average Zeta potential of (-36.5 ± 0.9) mV, 
and exhibiting a polydispersity index of 0.206 ± 0.014. 
 
 These values were produced for a stirring speed 
processing parameter of 12500 rpm. For the same 
(optimized) parameters, a control multiple emulsion was 
also produced, without encapsulated protein moieties, 
which produced the following values at time zero: 
hydrodynamic size of (206.15 ± 8.56) nm and average 
Zeta potential of (-19.83 ± 2.68) mV, and a 
polydispersity index of 0.277 ± 0.016. 
 
3.3. Statistical analyses. The experimental full factorial 
design of the type 2x2x2x3 (2
3
x3
1
) was designed and 
applied in order to evaluate the influence of four factors 
in the physicochemical properties of W/O/W multiple 
emulsions. The factors (independent variables) under 
scrutiny were (i) protein concentration in two levels, low 
(-1) and high (+1); soybean lecithin concentration in two 
levels, low (-1) and high (+1); poloxamer 188 
concentration in two levels, low (-1) and high (+1); and 
homogenization stirring speed in three levels, low (7500 
rpm), medium (10000 rpm) and high (12500 rpm). The 
evaluated dependent variables were the particle average 
hydrodynamic size (HS), the polydispersity index (PI) 
and the Zeta potential (ZP).  
 
Combination of the four factors resulted in a total of 24 
“treatments” (24 mixtures). Additionally, the central 
points of the first three factors were also inserted which, 
combined with the three stirring speed levels, resulted in 
additional three treatments that were replicated three 
times each. After each mixture (i.e. W/O/W multiple 
emulsion) was produced, via combination of the four 
factors, the variables HS, PI and ZP were measured in 
triplicate, for each mixture, and the averages (see Table 
2) were considered for the statistical analyses of the 
results. 
 
The statistical analysis performed was the analysis of 
variance (ANOVA), allowing to evaluate which factors 
are significant to explain the variation of each dependent 
variable (HS, PI and ZP). 
 
The significance level adopted for the statistical analyses 
was 5%, meaning that a factor was considered significant 
when the descriptive level (p-value) for that factor was 
lower than 0.05. Since HS and PI are the limiting factors 
for using the nasal route of administration, the main aim 
of this experimental full factorial design was to optimize 
a w/o/w multiple emulsion formulation with appropriate 
physicochemical parameters for the encapsulation of 
(hydrophilic) protein entities, envisaging its potential 
utilization in formulating an isotonic suspension for 
aerossolization. 
 
Response variables HS, PI and ZP did not exhibit any 
correlation between them (see Figure 1), as can be 
concluded from the correlation coefficients and p-values 
obtained for PI vs. ZP (r = 0.205, p-value = 0.338; p-
value > 0.05, hence no significant correlation exists 
between PI and ZP), PI vs. HS (r = 0.277, p-value = 
0.191; p-value > 0.05, hence no significant correlation 
exists between PI and HS) and HS vs. ZP (r = -0.360, p-
value = 0.084; p-value > 0.05, hence no significant 
correlation exists between HS and ZP). In this way, these 
variables could be analyzed individually, i.e., an 
ANOVA was performed for each one of them according 
to Montgomery
[26]
, Bates and Watts
[27]
 and Box and 
Draper.
[28] 
Otherwise, if any correlations were found 
among these response variables, a multivariate analysis 
of variance (MANOVA) would be in order. 
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Figure 1: Scatter plots (data means) showing the 
absence of correlation between PI vs. ZP (a), HS vs. 
PI (b), and HS vs. ZP (c). 
3.3.1. Statistical analysis of the variable HS. The 
analysis of variance (ANOVA) for the variable HS 
(particle average hydrodynamic size) (see Table 3) was 
produced under the assumption that p-values lower than 
0.05 were statistically significant, i.e., those values 
whose corresponding effect of the source (factor or 
interaction) was significant. Thus, from inspection of the 
data displayed in Table 3 one can see that the factors 
lecithin concentration (Lecithin), poloxamer 188 
concentration (P188) and homogenization stirring speed 
(RPM) were significant (values in bold in Table 3, under 
heading HS), meaning that a variation in the levels of 
these factors leads to a significant difference in the 
variation of HS. Additionally, and since no significant 
interaction effects were found, one can conclude that the 
factors Lecithin, P188 and RPM do promote variations in 
HS in an independent manner. 
 
 
 
 
 
 
 
 
 
 
Table 3. Statistical analyses of variance (ANOVA) for HS, PI and ZP, using adjusted sum of squares 
Note: The values in bold and highlighted in gray are statistically significant (p-value < 0.05) 
 
The levels (-1) for Lecithin, (-1) for P188 and 12500 for 
RPM were those who promoted the lower values for HS. 
Additionally, since the interactions between these factors 
were found not to be significant, one may conclude that 
the combination of these three levels (-1, -1, 12500) is 
the one that promotes the lower value for HS. Regarding 
the protein level, there is no statistically significant 
difference between the low and high levels. 
 
3.3.2. Statistical analysis of the variable PI. The 
analysis of variance (ANOVA) for the variable PI 
(polydispersity index) (see Table 3) shows that there was 
a statistically significant interaction between the factors 
Protein and Lecithin, as well as between Lecithin and 
RPM (homogenization stirring speed); in this way, those 
factors can not be analyzed independently. The influence 
of Lecithin on the value of PI depends on the level of 
Protein as well as on the level of RPM. Additionally, 
factor P188 was found to be significant, however without 
interaction with the remaining factors. Hence, factor 
P188 can be analyzed independently, but the levels of 
Lecithin must be analyzed within each level of Protein as 
well as within each level of RPM. The use of Lecithin is 
essential to decrease interfacial tension between the oily 
phase and the internal and external aqueous phases, and 
also to facilitate emulsification of the lipid matrix. 
Hence, notwithstanding the fact that Lecithin is used due 
to its high emulsification power able to provide 
Source 
Degrees of 
freedom 
Sum of squares Mean square F-value p-value 
HS PI ZP HS PI ZP HS PI ZP HS PI ZP HS PI ZP 
Protein 1 1 1 7.4 0.0001260 7.639 7.4 0.0001260 7.639 0.02 0.95 0.99 0.901 0.355 0.346 
Lecithin 1 1 1 5829.7 0.0000920 19.046 5829.7 0.0000920 19.046 12.92 0.70 2.47 0.006 0.426 0.151 
P188 1 1 1 3730.8 0.0011070 8.402 3730.8 0.0011070 8.402 8.27 8.36 1.09 0.018 0.018 0.324 
RPM 2 2 2 11495.5 0.0003876 128.453 5747.8 0.0001938 64.227 12.74 1.46 8.33 0.002 0.282 0.009 
Protein * Lecithin 1 1 1 154.1 0.0020350 5.358 154.1 0.0020350 5.358 0.34 15.37 0.69 0.573 0.004 0.426 
Protein * P188 1 1 1 392.9 0.0006100 1.025 392.9 0.0006100 1.025 0.87 4.61 0.13 0.375 0.060 0.724 
Protein * RPM 2 2 2 224.1 0.0001116 25.474 112.0 0.0000558 12.737 0.25 0.42 1.65 0.785 0.668 0.245 
Lecithin * P188 1 1 1 275.5 0.0002470 0.437 275.5 0.0002470 0.437 0.61 1.87 0.06 0.455 0.205 0.817 
Lecithin * RPM 2 2 2 914.0 0.0040716 61.010 457.0 0.0020358 30.505 1.01 15.37 3.96 0.401 0.001 0.059 
P188 * RPM 2 2 2 165.9 0.0004301 14.519 83.0 0.0002150 7.260 0.18 1.62 0.94 0.835 0.250 0.425 
Error 9 9 9 4060.9 0.0011919 69.411 451.2 0.0001324 7.712       
Total 23 23 23 27250.8 0.0104100 340.774          
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stabilization of the Wint/O interfaces, it has also been 
reported to decrease particle size in emulsions, a 
phenomenon that is mainly explained by its amphiphilic 
character.
[18,29] 
 
In fact, the results obtained in the present research effort 
for the PI values of the multiple emulsions (which were 
essentially monodisperse in all cases) were highly 
dependent on the level of Lecithin used. The PI value is 
dimensionless and scaled such that, for values smaller 
than 0.08, the sample is nearly monodisperse; normally, 
DLS can only give a monomodal distribution within the 
range 0.05-0.08. For PI values between 0.08 and 0.7, but 
far apart from 0.7, the sample is essentially 
monodisperse. Values of PI higher than 0.7 indicate that 
the sample has a very broad size distribution. The 
lipophilic portion of lecithin dissolves the lipid phase 
(i.e. lecithin becomes positioned at the edge of the lipid 
phase with its lipophilic tails directed towards the lipid 
phase while the hydrophilic head is directed towards the 
aqueous phase), hence promoting a long time 
stabilization in the interface of the emulsions.
[18,29]
 A 
dependency of PI was found on the concentration of 
Lecithin, since the complete coverage of the interface is 
affected by the selected concentration of emulsifier. 
 
The low level (-1) of P188 is the one that promotes the 
lower value of PI, and Figure 2 shows that for the low 
level (-1) of Protein it is the low level (-1) of Lecithin 
that promotes the lower value for PI, whereas for the 
high level (+1) of Protein it is the high level (+1) of 
Lecithin the one that promotes the lower value for PI.
 
 
Figure 2: Interaction plots (data means) for PI, showing the contributions of the interactions between Protein, 
Lecithin, P188 and RPM for the values of PI. 
 
Considering the interaction between RPM and Lecithin 
one can see that, by fixing the low level (-1) of Lecithin, 
as the level of homogenization stirring speed increases 
there is a tendency to obtain higher values of PI (see 
Figure 2). On the other hand, by fixing the high level 
(+1) of Lecithin, as the level of homogenization stirring 
speed increases there is a tendency to obtain lower values 
of PI (see Figure 2). The variable PI is explained by the 
model displayed as Equation (1). 
 
Figure 3 displays the three-dimensional surface response 
plots for the variable PI (polydispersity index), 
considering all factors that contribute to its minimization. 
 
 
 
 
Balcão et al.                                                                    European Journal of Biomedical and Pharmaceutical Sciences 
 
www.ejbps.com 
 
 
72 
 
 
Figure 3: Surface response three-dimensional plots for PI vs. RPM and P188 (a), PI vs. RPM and Lecithin (b), PI 
vs. P188 and Lecithin (c), PI vs. RPM and Protein (d), PI vs. P188 and Protein (e), and PI vs. Lecithin and 
Protein (f). 
 
PI = constant + effect of P188 + effect of Protein + effect of Lecithin 
+ effect of RPM + effect of the interaction (Protein ∗ Lecithin) 
+ effect of the interaction (Lecithin ∗ RPM) + Error                            (1) 
 
For the interpretation of the interaction between Lecithin 
and RPM, Figure 2 displays the interactions encountered 
for the variable PI. From inspection of Figure 2, one can 
notice that for the lower level of RPM (7500) lecithin in 
its lowest level (-1) is the one that provides the lower 
value of PI. However, for the higher level of RPM 
(12500) lecithin in its highest level (+1) is the one that 
provides the lower value of PI. Thus, from the statistical 
analysis performed to the experimental results obtained 
in the sequence of the full factorial design applied to 
produce the several W/O/W multiple emulsions, namely 
to the experimental results obtained for variables HS, ZP 
and PI of freshly prepared multiple emulsions, it can be 
concluded that the optimal multiple emulsion 
(considering a small particle hydrodynamic size 
associated to the lower polydispersity index) is the one 
whose formulation parameters in the factorial design are 
the following ones: Lecithin at the high level (+1), 
Protein at the high level (+1), Poloxamer 188 at the low 
level (-1), homogenization stirring speed at the high level 
(12500 rpm). In the coding performed (see Table 2), the 
emulsion that corresponds to these parameters has the 
code ME3/12500. 
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3.3.3. Statistical analysis of the variable ZP. The 
analysis of variance performed to variable ZP (see Table 
3, under heading ZP) shows that the only significant 
factor was RPM, whose p-value was lower than 0.05. 
This means that a variation in the levels of RPM 
promotes a significant variation in Zeta potential (ZP). 
From inspection of Table 3 it can also be observed that 
no significant interactions could be found, meaning that 
the effects of the levels of RPM upon the values of ZP do 
not depend on the levels of the remaining factors. 
 
4. CONCLUSIONS 
In this research effort, development and optimization of 
lipid nanoballoons housing protein entities integrating a 
multiple emulsion formulation was pursued, using a lipid 
with mild melting temperature for the discontinuous oily 
phase. Departing from the factorial planning designed 
and utilized in the preparation of the several multiple 
emulsions, one was able to verify unequivocally how 
each variable (protein, lecithin and poloxamer 188 
concentrations, and homogenization stirring speed) 
influenced on the physicochemical characteristics of the 
multiple emulsions. The statistical analysis performed to 
evaluate the results obtained (average particle 
hydrodynamic size, average polydispersity index and 
average Zeta potential) allowed verification of the 
influence of each parameter in the production of an 
optimal emulsion. Thus, from the comprehensive 
statistical analysis performed, it can be concluded that 
the optimum formulation for encapsulation of protein 
entities was multiple emulsion 3 (coded ME03) produced 
with a homogenization stirring speed of 12500 rpm. Two 
homogenization cycles of 10 min at high level (+1) of 
stirring speed (12500 rpm), the use of high level (+1) of 
protein concentration (0.015%, w/w), high level (+1) of 
lecithin concentration (0.75%, w/w), and low level (-1) 
of poloxamer 188 concentration (0.50%, w/w), were 
found to be critical variables for producing stable 
(aqueous-core) lipid nanoballoon dispersions. 
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